alexa Evo-Dev Of Hepatitis B Virus-induced Hepatocellular Carcinoma: Role Of Human APOBEC3 Cytidine Deaminases On Linking Inflammation And Cancers | 17923
ISSN: 2161-1165

Epidemiology: Open Access
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference on Epidemiology & Evolutionary Genetics
August 18-19, 2014 DoubleTree by Hilton Beijing, China

Guangwen Cao
Accepted Abstracts: Epidemiol
DOI: 10.4172/2161-1165.S1.009
Abstract
C hronic infection with hepatitis B virus (HBV) contributes to more than three quarters of hepatocellular carcinoma (HCC) cases worldwide. Genetic predispositions of human leukocyte antigens (HLAs) contribute to immune imbalance upon HBV infection, leading to chronic inflammation in liver. HBV demonstrates ?mutation-selection-adaptation?, an evolutionary process during hepatocarcinogenesis. Cytokines generated during chronic but active inflammation or antiviral cytokines such as interferons can up-regulate the expression of activation-induced cytidine deaminase (AID) and apolipoprotein B mRNA editing enzyme, catalytic polypeptides (APOBECs). These enzymes efficiently deaminate cytidine to uracil in DNA and/or RNA and generate G to A hypermutations both in viral and host genomes, thus editing HBV genome and increase viral mutation. Following immune/survival selections in the inflammatory microenvironment, the HBV mutants and cancer- initiating cells with somatic mutations such as p53 mutation contribute to the generation of HCC. Chronic inflammation provides ?fertile field? for somatic mutation, selection, and adaptation (evolutionary process) during HCC development. Genetic predispositions of inflammatory signaling molecules such as nuclear factor-kappaB (NF-κB), signal transducer and activator of transcription 3 (STAT3), HLAs, and some miRNAs contribute significantly to the generation of HCC-risk HBV mutations. Genomic variations of HCC caused by different etiological factors might be different but the common genomic variations should be important for the elucidation of HCC evolution. Genome-wide analysis of HBV integrations may help in clarifying the mechanisms of HBV-induced hepatocarcinogenesis and disease progression. RNA sequencing presents additional evidences of epigenetic modification during HCC evolution. Understanding the key genomic variations during HCC evolution might be essential for accurate prognosis prediction and efficient targeted treatment for this fatal malignancy. Prospective cohort studies are indispensable to identify the HBV-infected subjects who are more likely to develop and need specific intervention.
Biography
Guangwen Cao has completed his PhD from Second Military Medical University in 1995 and Postdoctoral training from Baylor College of Medicine in 2002. Currently, he chairs the Department of Epidemiology, Second Military Medical University. He is sponsored by Outstanding Young Scholar fund from NSFC and serves as the chief scientist for a national key basic research project (973-project) in evolution-development of cancers in China. As the corresponding author, he has published more than 100 papers in reputed journals.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version